 |
|
Click here to retrieve your archive of CME certificates obtained via HDCN
|
TBA |
Infectious Risk in Renal Replacement Therapy
Neil R. Powe, MD and Charmaine E. Lok, MD
|
TBA |
Multiple Myeloma: Novel Treatments and Role of Plasmapheresis
Peter M. Voorhees, MD and François Madoré, MD
|
TBA |
Is Peritoneal Dialysis Membrane Failure Inevitable with Long-term Use?
Wim Van Biesen, MD, PhD, Salim K. Mujais, MD, and Bengt Lindholm, MD, PhD
|
TBA |
Renal Diseases of Children in Adults
Friedhelm Hildebrandt, MD and Robert L. Chevalier, MD
|
TBA |
Nephrology Quiz and Questionnaire: Fluids and Electrolytes (Palmer) and Glomerular Disorders (Fervenza)
Biff F. Palmer, MD, and Frenando C. Fervenza, MD, PhD
|
TBA |
The Approaching Tidal Wave of Hypertension and Its Sequelae in the Young
Joseph T. Flynn, MD and Rae-Ellen W. Kavey, MD
|
TBA |
Vascular Calcification
Mathew Jay Budoff, MD and Markus Ketteler, MD
|
TBA |
Management of hyponatremia
Richard H. Sterns, MD; Horacio J. Adrogue, MD; and Joseph G. Verbalis, MD
|
TBA |
Diabetic Nephropathy
Amy Katherine Mottl, MD and Katherine R. Tuttle, MD
|
TBA |
Debates in Renal Disease: Combination of ACEI and ARB is More Efficacious than Monotherapy. Yes or No?
Hans Henrik Parving, MD, and Johannes F.E. Mann, MD (Moderator: Ricardo Correa-Rotter, MD)
|
TBA |
Thrombotic Microangiopathies
Jerry Appel, MD, and William F. Clark, MD
|
TBA |
The Changing Face of FSGS/MCD
Jai Radhakrishnan, MD; Daniel C. Cattran, MD; and Jeffrey B. Kopp, MD
|
TBA |
Hepatitis C and Renal Disease
Roy D. Bloom, MD and Robert S. Brown, Jr, MD
|
TBA |
Primary Care for Nephrologists: HIV Nephropathy
Arthur H. Cohen, MD and Jeffrey S. Berns, MD
|
1.5 |
Controlling Diabetes Mellitus by Targeting the Kidney
George L. Bakris, MD; Ernest M. Wright, PhD; Mark E. Molitch, MD.
|
1.5 |
Understanding the Kidney - Heart Connection
Claudio Ronco, MD; Edward A. Ross, MD; Tomas Berl, MD
|
1.5 |
Impact of Bundled Payments on Care for ESRD Patients
Raymond Hakim, MD; John Moran, MD; Allen Nissenson, MD; Rajiv Saran, MD; and Wolfgang Winkelmayer, MD. (Moderator: Jonathan Himmelfarb, MD)
|
1.5 |
New Frontiers in Chronic Kidney Disease-Mineral Bone Disorders
Isidro B. Salusky, MD; Orlando M. Gutierrez, MD, MMSc; David A. Bushinsky, MD. (Moderator: Myles S. Wolf, MD)
|
1.5 |
Hepatorenal Syndrome
Robert W. Schrier, MD; Hani M. Wadei, MD; Andrew Davenport, MD.
|
1.5 |
Innovations in Caring for Patients with Hyponatremia
Mitchell H. Rosner, MD; Richard H. Sterns, MD; and Biff F. Palmer, MD. (Moderator: Nicolaos E. Madias, MD)
|
1.5 |
Racial Disparities in Patients with Chronic Kidney Disease
L. Ebony Boulware, MD; John R. Sedor, MD; and Keith C. Norris, MD. (Moderators: Paul Smedberg, MD and Thomas Hostetter, MD)
|
1.0 |
Controversies in Anemia Management of Chronic Kidney Disease Patients
Rajiv Agarwal, MD; Kamyar Kalantar-Zadeh, MD. (Moderator: Andrew Fenves, MD)
|
1.5 |
The Role of Iron in Outpatient CKD Management
Csaba P. Kovesdy, MD; Jay Wish, MD; Daniel W. Coyne, MD. (Moderator: George Aronoff, MD)
|
1.5 |
Innovative Approaches and Prevention Strategies for Chronic Kidney Disease-Mineral and Bone Disorders
Adriana S. Dusso, PhD; Michal Melamed, MD; Kamyar Kalantar-Zadeh, MD, MPH, PhD. (Moderator: Maria Coco, MD)
|
1.5 |
Update in Transplant Immunology for the Clinician
Robert L. Fairchild, PhD; Elaine F. Reed, PhD; Flavio Vincenti, MD
(Moderator: Roslyn B. Mannon, MD)
|
 |
Identify recent discoveries in basic, translational, and clinical research in nephrology.
|
|
Construct new research questions in nephrology based on updated scientific and clinical advances in nephrology-related disciplines.
|
|
Translate recent advances in the areas of general nephrology, dialysis, transplantation, and hypertension into new standards and approaches to clinical care of patients with kidney diseases and related disorders.
|
|
|
See Individual Lecture Pages
|
|
 |
|
Date of Web Release:
See individual talks
CME Credit Eligible Through: April 30, 2011
AMA PRA Category 1 Credits™:
See individual talks
Target Audiences: Physicians, Researchers and Fellows-in-Training.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.
|
Chronic kidney disease affects 30-40 million Americans, of whom several
thousand require renal replacement therapy. These selected lectures
are chosen by the HDCN editor and ASN Postgraduate Medical Director
to reflect those areas of practice of greatest interest to the
clinician, and areas where recent progress has occurred. The
web extension of these ASN lectures will allow nephrologists
and other physicians who were unable to attend the live sessions
to gain similar benefit from these presentations.
|
ACCREDITATION AND DESIGNATION STATEMENTS: |
Accreditation Statement
The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CME Credit Designation Statement:
The American Society of Nephrology designates this educational activity for a maximum of
a specified number of
AMA PRA Category 1 Credits™ for each talk. Physicians should only claim credit commensurate with the extent of their participation in each portion of this activity.
Some of these sessions are supported by educational grants from industry. Please see each individual talk for details.
| FACULTY DISCLOSURE STATEMENTS : | It is the policy of ASN that all individuals in a position to control the content of ASN's sponsored CME activities are expected to provide full disclosure for both themselves and their spouse/partner, and indicate to the activity audience any relevant financial or other relationships held by themselves or their spouse/partner 1) with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial service(s) discussed in an educational presentation; and 2) with any commercial supporter(s) of the activity. All responses should reflect activities within the previous 12 months. This disclosure information is collected in accordance with the Accreditation Council for Continuing Medical Education (ACCME). Further, ASN requires that all faculty disclose at the time of their lecture, any planned discussion of investigational and/or off-label use of pharmaceutical products or devices within their presentation. Participants should note that the use of products outside U.S. Food and Drug Administration (FDA) approved labeling should be considered experimental and are advised to consult current prescribing information for approval indications.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in continuing medical education (CME), but rather to ensure that ASN CME activities promote quality and safety, are effective in improving medical practice, are based on valid content, and are independent of control from commercial interests and free of commercial bias. In addition, all faculty members were instructed to provide balanced, scientifically rigorous, and evidence-based presentations.
Faculty disclosures are posted on each individual talk page.
| DISCLOSURE OF UNLABELED USE: |
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved
indications, contraindications and warnings. Faculty disclosure about unlabeled or off-label use is posted on each individual talk page.
| ASN's PRIVACY/CONFIDENTIALITY POLICY: |
As a condition of your access and use of the Website, you agree not to use the Website for any purpose that is unlawful or inconsistent with the Agreement. ASN, in its sole discretion, is authorized to remove or delete any entries, information, materials or other content that violates these Terms of Use or that is otherwise objectionable. ASN reserves the right to investigate and prosecute violations of any of these Terms of Use to the fullest extent of the law. If Users fail to comply with these Terms of Use, ASN in its sole discretion may terminate the User's access to the website immediately without advance notice. These terms of use comprise an Agreement that is governed by the laws of the District of Columbia, which shall be the forum for any disputes.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
To complete this educational activity, the user will need Windows (XP or higher) or Macintosh (version 9.0 or higher) operating
software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have
an audio card with speakers. An audio player, either the Windows Media Player (download from www.microsoft.com) or
the Flash version 8.0 (download from www.adobe.com) is required, and either can be downloaded for free per instructions on the individual lecture pages. Flash version 8.0 is required for the full-screen slide version of the program. Acrobat Reader is required to print the CME certificate, and this can be download free from www.adobe.com.
For any questions concerning this specific activity please send an email to
 or email@asn-online.org, or call HDCN at 630-325-3276 during normal business hours, Chicago time (Central Standard Time).
For any general questions concerning ASN CME, please contact the American Society of Nephrology.
|
|
